Jason Aryeh sold $612K of Ligand Pharmaceuticals Incorporated (LGND)

Executed Oct 30, disclosed Nov 4, 4 days later.

Value, as filed

$612K

1,909 sh across 2 lots

Executed

Oct 30

the trade date, as filed

Disclosed

Nov 4

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason Aryeh Director profile →

Jason Aryeh (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $1.2M of LGND (5,000 sh across 2 lots, as filed), executed Jun 10.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 37 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason Aryeh in LGND

LGNDSALE Ligand Pharmaceuticals Incorporated $1.2M
5,000 sh across 2 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.7M
10,000 sh across 3 lots
Exec Sep 23 2025
Filed Sep 24 2025 · 5:30 PM ET